UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of Earliest Event Reported): September 7, 2012

 

STAAR Surgical Company
(Exact name of registrant as specified in its charter)

 

Delaware
(State or other jurisdiction
of incorporation)		 0-11634
(Commission File Number)		 95-3797439
(I.R.S. Employer
Identification No.)
1911 Walker Ave, Monrovia, California (Address of principal executive offices)   91016
(Zip Code)

 

 

                                    Not Applicable                                    
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

¨  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 
 

 

Item 5.02Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On September 7, 2012, the Board of Directors of STAAR Surgical Company elected Charles P. Slacik CPA to serve in a newly created seat pursuant to an increase in size of the Board from six to seven members. Mr.Slacik will join the Company’s Audit Committee. The Board approved providing Mr. Slacik with the standard director compensation for a director who serves as a member of the Audit Committee, pro-rated for the remaining portion of the 2012-2013 term.

 

The appointment of Mr. Slacik to the Board was not the result of any arrangement or understanding between him and any other person or entity. There are no transactions between Mr. Slacik or any member of his immediate family and the Company or any of its subsidiaries.

 

Item 7.01Regulation FD Disclosure.

 

On September 13, 2012, the Company published a press release regarding the election of Mr. Slacik to the Board. The Company announced that his election is a part of a planned transition, as the current chairman of the Audit Committee, Don Duffy, has advised the Board he intends to retire at the end of his current term in May, 2013. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by this reference.

 

The information furnished herewith pursuant to Item 7.01 of this Current Report, including Exhibit 99.1, shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. The information in Item 7.01 of this Current Report shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date of this Current Report, regardless of any general incorporation language in the filing.

 

Item 9.01Financial Statements and Exhibits

 

Exhibit No.   Description
     
99.1   Press release of the Company dated September 13, 2012.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

September 13, 2012 By: /s/ Barry G. Caldwell
       Barry G. Caldwell
       President and Chief Executive Officer